Abstract
CA 125 is an antigen associated with non-mucinous epithelial ovarian cancer, which is defined by OC 125 antibody developed by immunizing ovarian cancer cells. We have produced two monoclonal antibodies, 130-22 and 145-9, by using the human lung adenocarcinoma cell line PC-9. Both 130-22 and 145-9 antibodies recognized CA 125 antigen. However, the binding sites seemed to be separate from those of OC 125. Testing by 9 immunoradiometric assays (IRMA), using different combinations of the 3 monoclonal antibodies 130-22, 145-9 and OC 125 demonstrated that the best standard curve for detecting CA 125 could be obtained by a “simultaneous sandwich” assay based on a mixture of125I-labeled OC 125 and 130-22 or 145-9 coated beads. One-step IRMA, using 130-22 as a tracer and 145-9 as an immunoadsorbent, also showed good reproducibility and sensitivity for measuring CA 125. Antigens were detectable in the culture supernatants of PC-9 cells and 5 of 6 ovarian cancer and endometrial adenocarcinoma cells. These results indicate that one-step IRMA using 130-22 and 145-9 is useful for detecting CA 125 antigen.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Koprowski H, Steplewski Z, Mitchell K, et al: Colorectal carcinoma antigen detected by hybridoma antibodies.Somat Cell Genet 5: 957–972, 1979
Bast RC Jr, Feeney M, Lazarus H, et al: Reactivity of a monoclonal antibody with human ovarian carcinoma.J Clin Invest 68: 1331–1337, 1981
Hilkens J, Hilgers J, Buijs F, et al: Monoclonal antibodies against human milkfat globule membranes useful in carcinoma research.Proc Biol Fluids 31: 1013–1061, 1984
Sakahara H, Endo K, Nakajima K, et al: Serum CA 19-9 concentrations and computed tomography finding in patients with pancreatic carcinoma.Cancer 57: 1324–1326, 1986
Davis HM, Zurawski VR Jr, Bast RC Jr, et al: Characterization of the CA 125 antigen associated with human epithelial ovarian carcinomas.Cancer Research 46: 6143–6148, 1986
Bast RC JR, Klug TL, John ES, et al: A radioimmunoassay using monoclonal antibodies to monitor the course of epithelial ovarian cancer.N Engl J Med 309: 883–887, 1983
Klug TL, Bast RC Jr, Niloff JM, et al: Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 125) associated with human epithelial ovarian carcinoma.Cancer Res 44: 1048–1053, 1984
Matsuoka Y, Nakashima T, Endo K, et al: Recognition of ovarian cancer antigen CA 125 by murine monoclonal antibody produced by the immunization of lung cancer cells.Cancer Res 47: 6335–6340, 1987
Ehrlich PH, Moyle WR: Cooperative immunoassay: Ultrasensitive assays with mixed monoclonal antibodies.Science 221: 279–281, 1983
Ballet DH, Wands JR, Isselbacher KJ, et al: Serum alpha-fetoprotein levels in human disease: Perspective from a highly specific monoclonal radioimmunoassay.Proc Natl Acad Sci USA 81: 3869–3873, 1984
Ishiwata I, Ishiwata C, Soma M, et al: Establishment and characterization of two human ovarian endometrioid carcinoma cell lines (with or without squamous cell component).Gynecologic Oncology 25: 95–107, 1986
Cobbold SP, Waldmann H: A rapid solid-phase enzyme-linked binding assay for screening monoclonal antibodies to cell surface antigen.J Immunol Methods 44: 125–133, 1981
Hunter WM, Greenwood FC: Preparation of iodine- 131 labelled human growth hormone of high specific activity.Nature 194: 495–496, 1962
Masuho Y, Zalutsky M, Knapp RC, et al: Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinomas.Cancer Res 44: 2813–2819, 1984
Kuroki M, Yamaguchi A, Koga Y, et al: Antigenic reactivities of purified preparation of carcinoembryonic antigen (CEA) and related normal antigens using four different radioimmunoassay systems for CEA.J Immunol Method 60: 221–233, 1982
Scatchard G: The attraction of proteins for small molecules and ions.Ann NY Acad Sci 51: 660–672, 1949
Kabawat SE, Bast RC Jr, Bhan AK, et al: Tissue distribution of a coelomicepithelium-related antigen recognized by the monoclonal antibody OC 125.Intern J Gynecol Pathol 2: 275–285, 1983
Ikeda I, Sekiguchi K, Iinuma K, et al: Mathematical treatment of 2-site immunoradiometric assay (sandwich assay) at equilibrium-II: Dose-response curve and its sensitivity.Jpn J Nucl Med (Kakuigaku) 20: 723–731, 1983
Baum RP, Chatal JF, Saccavini JC, et al: Radioimmunotherapy with I-131 labeled monoclonal antibodies 19-9/anti-CEA and OC 125.J Nucl Med 27: p. 1019, 1986
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kunimatsu, M., Endo, K., Nakashima, T. et al. Development of new immunoradiometric assay for CA 125 antigen using two monoclonal antibodies produced by immunizing lung cancer cells. Ann Nucl Med 2, 73–79 (1988). https://doi.org/10.1007/BF03164948
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03164948